Table 1 Inhibitor series characterised and compared in this study.

From: Development of a characterised tool kit for the interrogation of NLRP3 inflammasome-dependent responses

Drug

Structure

Reference

P2X7 antagonists

CE-224,535

17

AZD9056

View full size image

18

25 (from [1]

View full size image

19

26 (from [1]

View full size image

19

Diarylsulfonylurea inflammasome inhibitor series

Glyburide

View full size image

20

CP-412,245

View full size image

20

CP-424,174

View full size image

20

CRID1

View full size image

21

CRID2

View full size image

21

MCC950

View full size image

21,22

NBC inflammasome inhibitor series

BC7

38

BC23

39

NBC6

24

NBC11

View full size image

24

NBC12

24

NBC13

24

NBC19

24

Caspase-1 inhibitor

VX-765

View full size image

23

  1. Drugs targeting different points of the NLRP3 pathway assessed in this study. Shown is the name, structure, and original reference for the compounds tested. Compounds tested belong to one of 4 inhibitor classes: P2X7 receptor inhibitors, diarylsulphonylurea inhibitors, NBC series inhibitors, and a caspase-1 inhibitor.